Cerebras Systems (CBRS): Breaking Down the Path to the $275 Target and +236% Upside

Key Takeaways

• The central $275 target reflects the arithmetic mean of roughly 11 current analyst price targets, which range from about $175 to $325 — an unusually wide spread.
• Cerebras Systems (CBRS) last traded near $81.71, so reaching $275 would require upside of roughly 236%, a very large move.
• The covering banks are broadly positive, with no Sell ratings and ratings clustered at Buy, Outperform, or Overweight.
• Supports include a differentiated wafer-scale architecture, roughly 111% trailing revenue growth, contracted capacity with OpenAI, and about $7.9 billion in cash.
• Key risks are heavy customer concentration, intensifying competition, persistent net losses, execution on cloud build-outs, and extreme share-price volatility since the May 2026 IPO.
• For more context, explore the ticker's Major News, Today's Price Move, Forecast, and Earnings pages.
• You can also track how AI evaluates shifting conditions by exploring Trending AI Robots.

Analyst Price Targets and Consensus View

Cerebras Systems Inc. (CBRS) is a semiconductor and AI infrastructure company whose wafer-scale engine (WSE) targets fast AI inference and training. Because the company only began trading publicly in May 2026, its analyst coverage is still young but unusually concentrated in bullish ratings.

The $275 central target is a rounded mean of verified individual targets. Recent examples include Barclays at $280, Mizuho at $300, Morgan Stanley at $279, Wedbush at $270, and Needham, Rosenblatt, and UBS each around $300. Freedom Capital Markets sits lower at $209, while one firm trimmed its target from $330 to $250 in early November. The full range of roughly $175 to $325 shows how much analysts disagree about execution risk and the durability of AI demand.

Aggregators describe the group as "Strong Buy" or "Moderate Buy," but the dispersion matters more than the label. The most conservative targets assume the company must prove it can convert contracted capacity into revenue on schedule, while the highest targets assume faster-than-expected deployment and hardware sales. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Where CBRS Stands Today and the Road to $275

At a last-verified price near $81.71, moving to $275 implies about 236% appreciation — a very large move even for a high-growth semiconductor name. The stock priced its IPO at $185, spiked to a 52-week high of $386.34, and has since fallen sharply, recently touching a 52-week low of $77.84. This makes the gap to the target as much a question of regaining investor confidence as one of pure fundamentals.

Trailing revenue reached roughly $680.7 million, up about 112% year over year, yet the company remains unprofitable, with a trailing diluted EPS near negative $5.14 and a net loss of about $487 million. With no meaningful P/E ratio to anchor valuation, the path to the target rests heavily on revenue acceleration and progress toward profitability.

Bullish Factors That Could Drive the Stock Higher

Cerebras' wafer-scale approach is genuinely differentiated, offering memory bandwidth advantages that analysts cite as a competitive moat against GPU-based rivals. Contracted, take-or-pay revenue tied to OpenAI — which Morgan Stanley estimates could approach 80% of near-term revenue — provides unusual visibility for a company this early in its commercial ramp. A roughly $7.9 billion cash position also funds the cloud build-out without immediate dilution pressure.

Consensus revenue forecasts project a jump from about $887 million in fiscal 2026 toward $2.96 billion in fiscal 2027, with EPS turning positive. Recent commercial agreements, including one with Oracle (ORCL) to offer wafer-scale systems through Oracle Cloud Infrastructure, broaden the customer base beyond a single hyperscaler.

Risks That Could Hold CBRS Back

Customer concentration is the clearest vulnerability. If the OpenAI relationship renegotiates or scales slower than contracted, the revenue base could compress quickly. Competition is intensifying — NVIDIA (NVDA) and Broadcom (AVGO) dominate AI silicon, and NVIDIA's acquisition of Groq assets signals how seriously incumbents treat low-latency inference.

Execution risk in building out large-scale cloud capacity is material, and the company's gross margin in the latest quarter was only about 14%. Share dilution has been significant, with shares outstanding up roughly 61% year over year. Finally, the stock's collapse from $386 to under $82 shows how quickly sentiment can unwind in a richly valued, pre-profitability name.

Technical Picture and Key Levels to Watch

Technically, the picture is weak. The stock trades well below its 50-day moving average near $161 and its 200-day average near $195, and its RSI has fallen into deeply oversold territory around 22. The $77.84 52-week low is the key support level to watch; a break below it would leave little chart-defined floor. On the upside, the prior IPO price of $185 and the $200 psychological level represent early resistance zones before any serious attempt at the $275 target.

Timeline and Key Events on the Horizon

Analyst price targets typically reflect a roughly 12-month research horizon, though newly public companies like Cerebras carry wider uncertainty. The next confirmed earnings report is scheduled for November 12, 2026, and will be pivotal for testing revenue guidance, gross-margin trajectory, and any updates on the OpenAI and Oracle agreements. Investors should also watch analyst revisions, capacity-deployment announcements, competitive product launches from NVIDIA and Broadcom, and any regulatory scrutiny of AI supply chains.

AI Daily Buy/Sell Signals

For traders seeking a more dynamic view of names like Cerebras, Tickeron's AI Daily Buy/Sell Signals apply artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from changing market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual review allows. Explore the AI Daily Buy/Sell Signals page to see how it can complement your research process.

My Take: Weighing the Bull and Bear Cases

Can Cerebras Systems reach $275? The question hinges on whether a pre-profitability company with explosive but concentrated revenue can sustain its hypergrowth while fending off the two largest players in AI silicon. The $275 mean target sits far above the current price, requiring roughly 236% appreciation, and the wide $175-to-$325 range signals genuine analyst disagreement about execution and competition rather than a confident consensus. Strong cash, contracted demand, and a differentiated architecture support the bull case, while customer concentration, mounting competition, losses, and recent price collapse form the bear case. Investors should monitor the November earnings report and subsequent analyst revisions before drawing conclusions. From what I see, this remains a high-conviction story worth following closely.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Notable companies

Industry description

Market Cap

High and low price notable news

Volume